Arrowhead Research | ARWR - Ebitda





Ebitda Veränderung Datum
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
Merck USD 6.3B 2.09B 2025-12
Moderna USD -1.26B 468M 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
TG Therapeutics USD 28.11M 23.58M 2026-03
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03
Xencor USD -51.05M 55.28M 2025-12